Cai Receives 2012 European Association of Nuclear Medicine Award
Professor Weibo Cai, principal investigator of the Molecular Imaging and Nanotechnology Laboratory won the 2012 European Association of Nuclear Medicine (EANM) Eckert & Ziegler Abstract Award. This is the 1st year that the Molecular Imaging and Nanotechnology laboratory submitted abstracts to the EANM Annual Congress. Both of the abstracts were selected as oral presentations.
The EANM Annual Congress takes place in Milan (Italy) from October 27-31, 2012. Being one of the leading manufacturers in Nuclear Medicine, the Eckert & Ziegler Strahlen- und Medizintechnik AG is the main sponsor of the yearly Abstract Awards Competition. Five best abstracts submitted to the EANM congress were selected for this award each year.
The abstract was entitled "In Vivo Targeting and Imaging of Tumor Vasculature with Radiolabeled, Antibody-Conjugated Nano-Graphene". For the first time, it was demonstrated that nano-graphene oxide can be specifically directed to the tumor in vivo. The versatile chemistry of graphene-based nanomaterials makes them suitable nanoplatforms for future biomedical research, such as cancer theranostics. Since the paper first came out in February 2012 in ACS Nano, it has attracted a lot of attention.
The work was highlighted in Chemical & Engineering News in February 2012. Immediately after the work came out online, Springer which is the leading global scientific publisher with ~2,000 journals and > 7,000 new book titles published every year, invited Cai to edit a book on a related topic. The book entitled "Engineering in Translational Medicine", with > 40 chapters which cover many areas of engineering and ~1000 pages, is scheduled for late 2013 or early 2014. In March, the Editor of Nanoscale invited Cai to write a Feature Review Article on this topic, which appeared in the July issue.
This work on nano-graphene was in collaboration with Professor Zhuang Liu at Soochow University, a long term collaborator of Cai's. In 2007, together they reported the first in vivo tumor targeting and imaging of single-walled carbon nanotubes in Nature Nanotechnology.
Date Published: 07/19/2012